Author:
Smolen J. S.,Breedveld F. C.,Schiff M. H.,Kalden J. R.,Emery P.,Eberl G.,van Riel P. L.,Tugwell P.
Publisher
Oxford University Press (OUP)
Subject
Pharmacology (medical),Rheumatology
Reference36 articles.
1. Felson DT, Anderson JJ, Boers M et al. The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. Arthritis Rheum1993;36:729–40.
2. van Gestel AM, van Riel PLCM. Evaluation of early rheumatoid arthritis disease activity and outcome. Baillière's Clin Rheumatol1997;11:49–63.
3. Boers M, Tugwell P, Brooks PM. Progress towards optimal trial end‐points in rheumatoid arthritis. BioDrugs1997;7:40–50.
4. Goldsmith CH, Boers M, Bombardier C, Tugwell P. Criteria for clinically important changes in outcomes: development, scoring and evaluation of rheumatoid arthritis patient and trial profiles. J Rheumatol1993;20:561–5.
5. van Riel PLCM, van Gestel AM, van de Putte LBA. Development and validation of response criteria in rheumatoid arthritis: steps towards an international consensus on prognostic markers. Br J Rheumatol1996;35(Suppl. 2):4–7.
Cited by
783 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献